{
    "Trade/Device Name(s)": [
        "BioPlex\u00ae 2200 Rubella and CMV IgM Kit",
        "BioPlex\u00ae 2200 Rubella and CMV IgM Calibrator Set",
        "BioPlex\u00ae 2200 Rubella and CMV IgM Control Set"
    ],
    "Submitter Information": "Bio-Rad Laboratories, Inc.",
    "510(k) Number": "K092587",
    "Predicate Device Reference 510(k) Number(s)": [
        "K010668",
        "K933549"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LFX",
        "LKQ",
        "LFZ",
        "JIX",
        "JJX"
    ],
    "Summary Letter Date": "November 30, 2010",
    "Summary Letter Received Date": "December 1, 2010",
    "Submission Date": "November 30, 2010",
    "Regulation Number(s)": [
        "21CFR866.3510"
    ],
    "Regulation Name(s)": [
        "Rubella Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "immunology",
        "serology"
    ],
    "Analyte(s)": [
        "Rubella IgM",
        "Cytomegalovirus (CMV) IgM"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Potassium EDTA plasma",
        "Sodium heparin plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BioPlex 2200 System"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex flow immunoassay",
        "Fluorescent detection"
    ],
    "Methodologies": [
        "Multiplex immunoassay",
        "Qualitative antibody detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Calibrator",
        "Control",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for Bio-Rad BioPlex 2200 Rubella and CMV IgM kit for multiplex detection of IgM antibodies to Rubella and CMV in serum and plasma using a multiplex flow immunoassay",
    "Indications for Use Summary": "Intended for the qualitative detection of IgM antibodies to Rubella and CMV in human serum and potassium EDTA or sodium heparin plasma, as an aid in diagnosis of current or recent infection in suspected individuals including women of child-bearing age, not for blood donor screening or point-of-care use.",
    "fda_folder": "Microbiology"
}